Literature DB >> 21349420

Neuroendocrine tumors: current recommendations for diagnosis and surgical management.

Saju Joseph1, Yi-Zarn Wang, J Philip Boudreaux, Lowell B Anthony, Richard Campeau, Daniel Raines, Thomas O'Dorisio, Vay Liang Go, Aaron I Vinik, Jason Cundiff, Eugene A Woltering.   

Abstract

Neuroendocrine tumors (NETs) are rare neoplasms found in diverse locations within the body. These tumors are commonly classified by the primary tumor's location, further subclassified by their differentiation, and finally segregated by their ability to hypersecrete peptides or amines. A number of groups have summarized their recommendations for diagnosis and therapy; however, the rarity of these lesions makes prospective randomized multiinstitutional trials difficult. Thus, these "consensus statements" often remain opinion-based. The authors have collaboratively developed a consensus on the current diagnostic work-up necessary for patients with NETs to help clinicians with this confusing field and followed this with some of the more advanced surgical techniques and considerations that are currently only available in specialty centers to show the evolving management of NETs.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21349420     DOI: 10.1016/j.ecl.2010.08.004

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  9 in total

1.  The treatment of neuroendocrine tumors with long-acting somatostatin analogs: a single center experience with lanreotide autogel.

Authors:  A Bianchi; L De Marinis; A Fusco; F Lugli; L Tartaglione; D Milardi; M Mormando; A P Lassandro; R Paragliola; C A Rota; S Della Casa; S M Corsello; M G Brizi; A Pontecorvi
Journal:  J Endocrinol Invest       Date:  2011-11-07       Impact factor: 4.256

2.  Pancreatic Neuroendocrine Tumors: an Update.

Authors:  Alessandro Paniccia; Barish H Edil; Richard D Schulick
Journal:  Indian J Surg       Date:  2015-10-13       Impact factor: 0.656

3.  Are contrast media required for (68)Ga-DOTATOC PET/CT in patients with neuroendocrine tumours of the abdomen?

Authors:  Marius E Mayerhoefer; Matthias Schuetz; Silvia Magnaldi; Michael Weber; Siegfried Trattnig; Georgios Karanikas
Journal:  Eur Radiol       Date:  2011-11-12       Impact factor: 5.315

4.  Neuroendocrine apendicopathy in morphologically normal appendices of patients with diagnosis of acute appendicitis: Diagnostic study.

Authors:  Andy Petroianu; Thiago Vinicius Villar Barroso; Marcelo Araújo Buzelin; Bárbara De Melo Theobaldo; Luciene Simões De Assis Tafuri
Journal:  Ann Med Surg (Lond)       Date:  2020-11-06

Review 5.  Update on pancreatic neuroendocrine tumors.

Authors:  Logan R McKenna; Barish H Edil
Journal:  Gland Surg       Date:  2014-11

6.  Imaging in neuroendocrine tumors: an update for the clinician.

Authors:  Jessica E Maxwell; James R Howe
Journal:  Int J Endocr Oncol       Date:  2015

7.  Forty-Three-Year-Old Female with Dopamine Secreting Pheochromocytoma of the Adrenal Gland.

Authors:  Tyler Haden; Marcin Zuberek; Naveen Pokala
Journal:  Case Rep Urol       Date:  2017-08-31

8.  Endoscopic submucosal dissection combined with adjuvant chemotherapy for early-stage neuroendocrine carcinoma of the esophagus: A case report.

Authors:  Nan Tang; Zhen Feng
Journal:  World J Clin Cases       Date:  2022-04-06       Impact factor: 1.337

9.  Large-Cell Neuroendocrine Carcinoma of the Esophagus: A Case from Saudi Arabia.

Authors:  Hadi Kuriry; Abdul Monem Swied
Journal:  Case Rep Gastroenterol       Date:  2015-10-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.